In Historic Announcement, the World Health Organization (WHO) Proposes Removing Cannabis From Most Dangerous Drug Category
Marijuana Stocks, Finance, & InvestingUncategorized July 19, 2019 MJ Shareholders
Following a lengthy review process, international opponents of the ‘war on drugs’ are applauding the World Health Organization (WHO) move toward removing cannabis from its placement in the drug category reserved for the most dangerous substances.
Currently, whole-plant marijuana and cannabis resin are considered a schedule IV substance, indicating that any medical uses for the substance are outweighed by their potential for abuse. The scheduling was originally created in 1961 by a United Nations treaty on ‘Narcotic Drugs,’ as a means of setting an international framework for medical research, trade, and legislation.
If removed from schedule IV, which is shared by substances such as heroin and cocaine, it would signify that world health experts are acknowledging cannabis’s medical applications, allowing United Nations member states to move forward more freely with cannabis reform and give health professionals much more free reign to conduct research on the medical benefits and applications of marijuana.
It would also clear up the confusion behind the international trade of cannabidiol and CBD products. If the WHO reclassification is approved, it would legalize the trade of CBD products containing less than 0.2% THC (the psychoactive compound found in marijuana).
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers